(0.15%) 5 099.25 points
(0.53%) 38 586 points
(0.41%) 17 722 points
(0.38%) $79.25
(-0.34%) $2.03
(-0.05%) $2 308.50
(-0.15%) $26.79
(0.39%) $966.40
(-0.07%) $0.932
(-0.20%) $10.97
(-0.12%) $0.797
(0.65%) $91.72
0.46% ¥ 2 644.00
Live Chart Being Loaded With Signals
CMIC HOLDINGS Co., Ltd. provides various services for the pharmaceutical industry in Japan. The company operates in five segments: Contract Research Organization, Contract Development and Manufacturing Organization, Contract Sales Organization, Healthcare, and Innovative Pharma Model...
Stats | |
---|---|
Dzisiejszy wolumen | 283 600 |
Średni wolumen | 40 111.00 |
Kapitalizacja rynkowa | 44.64B |
EPS | ¥0 ( 2024-04-26 ) |
Następna data zysków | ( ¥0 ) 2024-07-29 |
Last Dividend | ¥5.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 8.48 |
ATR14 | ¥3.11 (0.00%) |
Wolumen Korelacja
CMIC HOLDINGS Co., Ltd. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
CMIC HOLDINGS Co., Ltd. Korelacja - Waluta/Towar
CMIC HOLDINGS Co., Ltd. Finanse
Annual | 2023 |
Przychody: | ¥104.70B |
Zysk brutto: | ¥24.70B (23.59 %) |
EPS: | ¥416.23 |
FY | 2023 |
Przychody: | ¥104.70B |
Zysk brutto: | ¥24.70B (23.59 %) |
EPS: | ¥416.23 |
FY | 2022 |
Przychody: | ¥108.46B |
Zysk brutto: | ¥26.26B (24.21 %) |
EPS: | ¥469.41 |
FY | 2021 |
Przychody: | ¥85.79B |
Zysk brutto: | ¥17.73B (20.66 %) |
EPS: | ¥111.87 |
Financial Reports:
No articles found.
CMIC HOLDINGS Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥10.00 (N/A) |
¥0 (N/A) |
¥5.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥2.50 | 2004-09-27 |
Last Dividend | ¥5.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 39 | -- |
Total Paid Out | ¥394.60 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.76 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.88 | |
Div. Directional Score | 7.89 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8255.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7616.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
6817.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
6171.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
4912.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
4072.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
3288.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
2335.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
9535.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8020.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0572 | 1.500 | 8.86 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0785 | 1.200 | 7.38 | 8.86 | [0 - 0.3] |
returnOnEquityTTM | 0.147 | 1.500 | 9.48 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.01 | 0.800 | 4.97 | 3.97 | [1 - 3] |
quickRatioTTM | 1.503 | 0.800 | 5.87 | 4.69 | [0.8 - 2.5] |
cashRatioTTM | 0.617 | 1.500 | 7.69 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0385 | -1.500 | 9.36 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 57.84 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 453.56 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 453.56 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0737 | -1.500 | 9.71 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.223 | 1.000 | 9.61 | 9.61 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0745 | 1.000 | -0.509 | -0.509 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 2.93 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 1.372 | 0.800 | 4.19 | 3.35 | [0.5 - 2] |
Total Score | 11.90 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 8.38 | 1.000 | 9.25 | 0 | [1 - 100] |
returnOnEquityTTM | 0.147 | 2.50 | 9.67 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 453.56 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.702 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 453.56 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.740 | 1.500 | -8.27 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0823 | 1.000 | -0.443 | 0 | [0.1 - 0.5] |
Total Score | 3.88 |
CMIC HOLDINGS Co., Ltd.
CMIC HOLDINGS Co., Ltd. provides various services for the pharmaceutical industry in Japan. The company operates in five segments: Contract Research Organization, Contract Development and Manufacturing Organization, Contract Sales Organization, Healthcare, and Innovative Pharma Model. It offers clinical trial services, including clinical operations and trials, data management, clinical caretaker, medical writing, patient recruitment, pharmacovigilance, project management, audit and quality assurance, and statistical analysis; and clinical site network, CMC, drug development, health economics and outcome research, market entry/out-licensing, medical devices and in vitro diagnostic consulting, medical writing, national health insurance pricing, and product life cycle management consulting services. The company also provides development and manufacturing services, including commercial supply, contract development and manufacturing, investigational product manufacturing, packaging and labeling, release and stability tests, technology transfer, as well as formulation, process, and analytical development services; and laboratory services, such as bioanalysis and GLP analysis, biomarkers, CMC and GMP analysis, large molecule, oligonucleotides, small molecule, and toxicity, as well as safety pharmacology, in vitro and in vivo, and non-clinical studies. In addition, it offers patient and healthcare services, such as drug adherence support program, harmo, Helc+, prescription drug database, and selcheck services; and post-marketing surveillance, self-inspection, regulatory affairs consulting, regulatory submissions and correspondence, sales and marketing, clinical research coordinating, clinical site administration, and site management services. CMIC HOLDINGS Co., Ltd. has a partnership with Science 37, Inc. to decentralize clinical trials and enhance the development of treatments. The company was incorporated in 1985 and is headquartered in Tokyo, Japan.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej